Ascend Wellness Holdings (AAWH) Other Non-Current Assets (2020 - 2026)
Ascend Wellness Holdings (AAWH) posted quarterly Other Non-Current Assets of $11.3 million for Q1 2026, down 26.97% year-over-year from $15.5 million in Q1 2025, and down 24.54% quarter-over-quarter from $15.0 million in Q4 2025.
Ascend Wellness Holdings (AAWH) Other Non-Current Assets (2020 - 2026) Analysis & Trends
Ascend Wellness Holdings' Other Non-Current Assets history runs 7 years deep, the most recent figure standing at $11.3 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets fell 26.97% year-over-year to $11.3 million; the TTM figure through Mar 2026 stood at $11.3 million (down 26.97% YoY), while the FY2025 annual figure was $15.0 million, down 8.74% from the prior year.
- Other Non-Current Assets for Q1 2026 stood at $11.3 million, down from $15.0 million in the prior quarter.
- The five-year high for Other Non-Current Assets was $25.7 million in Q1 2024, with the low at $11.3 million in Q1 2026.
- The 5-year median for Other Non-Current Assets is $19.3 million (2022), against an average of $18.4 million.
- The sharpest annual moves came in 2024 and 2025: Other Non-Current Assets jumped 31.1% in 2024, then plunged 39.76% in 2025.
- Ascend Wellness Holdings' Other Non-Current Assets stood at $19.3 million in 2022, then grew by 19.59% to $23.1 million in 2023, then decreased by 28.77% to $16.4 million in 2024, then dropped by 8.74% to $15.0 million in 2025, then declined by 24.54% to $11.3 million in 2026.
- Business Quant data shows AAWH's Other Non-Current Assets at $11.3 million in Q1 2026, $15.0 million in Q4 2025, and $15.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 56.35 Mn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 1.79 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 384.00 Mn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 503.80 Mn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 239.50 Mn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 1.06 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 59.30 Mn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 304.00 Mn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 13.00 Mn |
| 10 | Ascend Wellness Holdings | 95.41 Mn | 28.41 Mn | 45.49 Mn | 12.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.00 Mn |
| Mar 31, 2026 | 11.31 Mn |
| Dec 31, 2025 | 14.99 Mn |
| Sep 30, 2025 | 15.34 Mn |
| Jun 30, 2025 | 15.37 Mn |
| Mar 31, 2025 | 15.49 Mn |
| Dec 31, 2024 | 16.43 Mn |
| Sep 30, 2024 | 18.24 Mn |
| Jun 30, 2024 | 19.89 Mn |
| Mar 31, 2024 | 25.71 Mn |
| Dec 31, 2023 | 23.06 Mn |
| Sep 30, 2023 | 19.77 Mn |
| Jun 30, 2023 | 19.95 Mn |
| Mar 31, 2023 | 19.61 Mn |
| Dec 31, 2022 | 19.28 Mn |
| Sep 30, 2022 | 18.84 Mn |
| Jun 30, 2022 | 19.93 Mn |
| Mar 31, 2022 | 19.93 Mn |
| Dec 31, 2021 | 19.57 Mn |
| Sep 30, 2021 | 19.76 Mn |